Ruxolitinib for Emergency Treatment of COVID‐19–Associated Cytokine Storm: Findings From an Expanded Access Study

Authors

Institutions

Publication Details

Journal
The Clinical Respiratory Journal
Published
2025-04-01
DOI
https://doi.org/10.1111/crj.70050
Citations
4
Primary Topic
COVID-19 Clinical Research Studies
Type
article
Field-Weighted Citation Impact
5.58

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Ruxolitinib for Emergency Treatment of COVID‐19–Associated Cytokine Storm: Findings From an Expanded Access Study

Peg Squier, Nikhil Jagan, JE Hamer‐Maansson, Jeffrey Weinstein et al.
4 citations
The Clinical Respiratory Journal
COVID-19 Clinical Research Studies
5.58
article

Ruxolitinib for Emergency Treatment of COVID‐19–Associated Cytokine Storm: Findings From an Expanded Access Study

Peg Squier, Nikhil Jagan, JE Hamer‐Maansson, Jeffrey Weinstein, Shawnta Lorthridge‐Jackson
article en
4 citations

Abstract

No abstract available for this paper.
The Clinical Respiratory JournalVol. 19(4)
Creighton University (US), Health Net (US), Incyte (United States) (US)
Incyte
Good health and well-being
Openalex Percentile: Top 4%
COVID-19 Clinical Research Studies
5.58
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.